RxDoctor Payments Data

Leila Mady, MD

Otolaryngology · Baltimore, MDNPI 1215355078

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.5%), consulting fees and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Atos Medical Inc at 44.4% of the total. Reporting peaked in 2024 at $1,534 and has fallen 90.9% since, to $139 in 2025.

$3,296in general payments, 2019–2025

Across 19 payments — averaging $173.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atos Medical Inc$1K
  • Stryker$825
  • Baxter Healthcare$288
  • Aroa Biosurgery Incorporated$250
  • Johnson & Johnson$249
  • Ambu Inc.$114
  • plus $108 from 1 others

What the payments were for

  • Consulting fees$1,46344%
  • Food & beverage$1,63049%
  • Education$2046%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atos Medical Inc2$1,463
Stryker7$825
Baxter Healthcare2$288
Aroa Biosurgery Incorporated1$250
Johnson & Johnson(2 entities)4$249
Ambu Inc.2$114
Acera Surgical, Inc.1$108

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,296 in reported general payments places this provider in the 75th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$150,779
Medicare patients
170
Services billed
589

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →